Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

Abstract

Corticotropin (ACTH)-independent macronodular adrenal hyperplasia (AIMAH) is a heterogeneous condition in which cortisol secretion may be mediated by gastrointestinal peptide (GIP), vasopressin, catecholamines and other hormones. We studied the expression profile of AIMAH by genomic cDNA microarray analysis. Total RNA was extracted from eight tissues (three GIP-dependent) and compared to total RNA obtained from adrenal glands from 62 normal subjects. Genes had to be altered in 75% of the patients, and be up- or downregulated at a cutoff ratio of at least 2.0; 82 and 31 genes were found to be consistently up- and downregulated, respectively. Among the former were regulators of transcription, chromatin remodeling, and cell cycle and adhesion. Downregulated sequences included genes involved in immune responses and insulin signaling. Hierarchical clustering correlated with the two main AIMAH diagnostic groups: GIP-dependent and non-GIP-dependent. The genes encoding the 7B2 protein (SGNE1) and WNT1-inducible signaling pathway protein 2 (WISP2) were specifically overexpressed in the GIP-dependent AIMAH. For these, and six more genes, the data were validated by semiquantitative amplification in samples from a total of 32 patients (the original eight, six more cases of AIMAH, and 18 other adrenocortical hyperplasias and tumors) and the H295R adrenocortical cancer cell line. In conclusion, our data confirmed AIMAH's clinical heterogeneity by identifying molecularly distinct diagnostic subgroups. Several candidate genes that may be responsible for AIMAH formation and/or progression were also identified, suggesting pathways that affect the cell cycle, adhesion and transcription as possible mediators of adrenocortical hyperplasia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Ai Z, Fischer A, Spray DC, Brown AM and Fishman GI . (2000). J. Clin. Invest., 105, 161–171.

  • Bauman A and Bauman CG . (1982). JAMA, 248, 3140–3141.

  • Bergeron F, Sirois F and Mbikay M . (2002). FEBS Lett., 512, 259–262.

  • Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bourdeau I, Bei T, Vincent C, Perlemoine K, Gicquel C, Bertagna X and Stratakis CA . (2002). The Endocrine Society's 84th Annual Meeting, Vol. Program & Abstracts. San Francisco, CA, USA, 319pp.

    Google Scholar 

  • Bornstein SR, Stratakis CA and Chrousos GP . (1999). Ann. Intern. Med., 130, 759–771.

  • Boston BA, Mandel S, LaFranchi S and Bliziotes M . (1994). J. Clin. Endocrinol. Metab., 79, 890–893.

  • Boulle N, Logie A, Gicquel C, Perin L and Le Bouc Y . (1998). J. Clin. Endocrinol. Metab., 83, 1713–1720.

  • Bourdeau I, D'Amour P, Hamet P, Boutin JM and Lacroix A . (2001). J. Clin. Endocrinol. Metab., 86, 5534–5540.

  • Bourdeau I, Lacroix L, Kirschner LS, Costouros NG, Lorang D and Stratakis CA . (2002). Am. J. Hum. Genet., 71, 189.

  • Bourdeau I and Stratakis CA . (2002). Ann. NY Acad. Sci., 968, 240–255.

  • Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL and Marx SJ . (1997). Science, 276, 404–407.

  • Colledge M and Scott JD . (1999). Trends Cell Biol., 9, 216–221.

  • Conacci-Sorrell M, Zhurinsky J and Ben-Ze'ev A . (2002). J. Clin. Invest., 109, 987–991.

  • Fearon ER and Vogelstein B . (1990). Cell, 61, 759–767.

  • Figueiredo BC, Stratakis CA, Sandrini R, DeLacerda L, Pianovsky MA, Giatzakis C, Young HM and Haddad BR . (1999). J. Clin. Endocrinol. Metab., 84, 1116–1121.

  • Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M and Nakamura Y . (2001). Cancer Res., 61, 7722–7726.

  • Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM and Hanash SM . (2003). Am. J. Pathol., 162, 521–531.

  • Goldstein LS . (2001). Proc. Natl. Acad. Sci. USA, 98, 6999–7003.

  • Hamwi GJ, Serbin RA and Kruger FA . (1957). N. Engl. J. Med., 257, 1153.

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW . (1998). Science, 281, 1509–1512.

  • Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O and Vainio S . (2002). Endocrinology, 143, 4358–4365.

  • Heppner C, Reincke M, Agarwal SK, Mora P, Allolio B, Burns AL, Spiegel AM and Marx SJ . (1999). J. Clin. Endocrinol. Metab., 84, 216–219.

  • Janssens B, Staes K and van Roy F . (1999). Biochim. Biophys. Acta, 1447, 341–347.

  • Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, Haraguchi K and Akiyama T . (2002). Nat. Cell Biol., 4, 323–327.

  • Kartheuser A, Walon C, West S, Breukel C, Detry R, Gribomont AC, Hamzehloei T, Hoang P, Maiter D, Pringot J, Rahier J, Khan PM, Curtis A, Burn J, Fodde R and Verellen-Dumoulin C . (1999). J. Med. Genet., 36, 65–67.

  • Kikuchi E, Yanaihara H, Nakashima J, Homma K, Ohigashi T, Asakura H, Tachibana M, Shibata H, Saruta T and Murai M . (2000). Biomed. Pharmacother., 54 (Suppl 1), 194s–197s.

  • Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS and Stratakis CA . (2000). Nat. Genet., 26, 89–92.

  • Kjellman M, Kallioniemi OP, Karhu R, Hoog A, Farnebo LO, Auer G, Larsson C and Backdahl M . (1996). Cancer Res., 56, 4219–4223.

  • Koch CA, Bornstein SR, Chrousos GP and Stratakis CA . (2000). Med. Klin., 95, 224–230.

  • Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R Flanagam R and Hamet P . (1992). N. Engl. J. Med., 327, 974–980.

  • Lacroix A, Ndiaye N, Tremblay J and Hamet P . (2001). Endocr. Rev., 22, 75–110.

  • Lacroix A, Tremblay J, Rousseau G, Bouvier M and Hamet P . (1997). N. Engl. J. Med., 337, 1429–1434.

  • Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, Narboni G, Mahoudeau J and Saez JM . (1998). J. Clin. Endocrinol. Metab., 83, 4514–4519.

  • Marchesa P, Fazio VW, Church JM and McGannon E . (1997). Dis. Colon Rectum, 40, 1023–1028.

  • Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P and Lacroix A . (2000). J. Clin. Endocrinol. Metab., 85, 3531–3536.

  • N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L and Lacroix A . (1999). J. Clin. Endocrinol. Metab., 84, 2616–2622.

  • N'Diaye N, Tremblay J, Hamet P, De Herder WW and Lacroix A . (1998). J. Clin. Endocrinol. Metab., 83, 2781–2785.

  • Pang S, Becker D, Cotelingam J, Foley Jr TP and Drash AL . (1981). Pediatrics, 68, 242–246.

  • Park B, Nguyen NT, Dutt P, Merdek KD, Bashar M, Sterpetti P, Tosolini A, Testa JR and Toksoz D . (2002). J. Biol. Chem., 277, 45361–45370.

  • Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D and Levine AJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 14717–14722.

  • Perbal B . (2001). Mol. Pathol., 54, 57–79.

  • Rainey WE, Bird IM and Mason JI . (1994). Mol. Cell Endocrinol., 100, 45–50.

  • Rampazzo C, Gallinaro L, Milanesi E, Frigimelica E, Reichard P and Bianchi V . (2000). Proc. Natl. Acad. Sci. USA, 97, 8239–8244.

  • Reincke M, Beuschlein F, Slawik M and Borm K . (2000). Eur. J. Clin. Invest., 30 (Suppl 3), 63–68.

  • Reincke M, Karl M, Travis W and Chrousos GP . (1993). J. Clin. Endocrinol. Metab., 77, 1419–1422.

  • Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM and Mahoudeau J . (1992). N. Engl. J. Med., 327, 981–986.

  • Saxena N, Banerjee S, Sengupta K, Zoubine MN and Banerjee SK . (2001). Mol. Cell. Biochem., 228, 99–104.

  • Semenza GL . (2000). Genes Dev., 14, 1983–1991.

  • Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Roher HD, Delbridge L and Robinson BG . (2002). J. Clin. Endocrinol. Metab., 87, 3467–3474.

  • Skogseid B, Larsson C, Lindgren PG, Kvanta E, Rastad J, Theodorsson E, Wide L, Wilander E and Oberg K . (1992). J. Clin. Endocrinol. Metab., 75, 76–81.

  • Stratakis C . (2003). Trends Endocrinol Metab., 14, 404–410.

  • Stratakis CA and Kirschner LS . (1998). Horm. Metab. Res., 30, 456–463.

  • Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP and Papanicolaou DA . (1999). Ann. Intern. Med., 131, 585–591.

  • Suwa T, Chen M, Hawks CL and Hornsby PJ . (2003). J. Endocrinol., 178, 149–158.

  • Suzuki H, Shibata H, Maruyama T, Ishimura Y and Saruta T . (1995). Steroids, 60, 42–47.

  • Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL . (2000). Am. J. Pathol., 157, 411–421.

  • Tetsu O and McCormick F . (1999). Nature, 398, 422–426.

  • Wakatsuki S, Sasano H, Matsui T, Nagashima K, Toyota T and Horii A . (1998). Hum. Pathol., 29, 302–306.

  • Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E and Spiegel AM . (1991). N. Engl. J. Med., 325, 1688–1695.

  • Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I and Leder P . (1999). Cell, 96, 689–700.

  • Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M and Hirohashi S . (2003). Hepatology, 37, 528–533.

  • Zhang JS, Nelson M, Wang L, Liu W, Qian CP, Shridhar V, Urrutia R and Smith DI . (1998). Genomics, 54, 149–154.

  • Zhao J, Speel EJ, Muletta-Feurer S, Rutimann K, Saremaslani P, Roth J, Heitz PU and Komminoth P . (1999). Am. J. Pathol., 155, 1039–1045.

  • Zwermann O, Beuschlein F, Mora P, Weber G, Allolio B and Reincke M . (2000). Eur. J. Endocrinol., 142, 689–695.

Download references

Acknowledgements

The authors wish to thank the physicians who referred the patients, the nursing staff for conducting the endocrine investigation, and the patients and their families. We also thank Dr William E Farrell (Keele University, UK) for his critical review of the manuscript and useful suggestions. Isabelle Bourdeau was a fellow of the Fonds de la recherche en santé du Québec, and this work was supported in part by Grant MT-13189 from the Canadian Institutes of Health Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Constantine A Stratakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bourdeau, I., Antonini, S., Lacroix, A. et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23, 1575–1585 (2004). https://doi.org/10.1038/sj.onc.1207277

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207277

Keywords

This article is cited by

Search

Quick links